肝線維症治療薬市場：世界及び中国市場分析・予測（～2024年）

• 英文タイトル：Liver Fibrosis Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

• レポートコード：C9J01100 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥444,000 (USD3,000)	▷ お問い合わせ
Site License	￥562,400 (USD3,800)	▷ お問い合わせ
Global Site License	￥740,000 (USD5,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

世界及び中国における肝線維症治療薬市場について調査・分析したレポートで、肝線維症治療薬の世界市場動向、市場規模、主要企業情報などが含まれています。肝線維症治療薬の種類別には、インターフェロン、マロチ脂質、ヌクレオシド、その他に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・肝線維症治療薬産業の概要 ・肝線維症治療薬の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国の肝線維症治療薬市場 2014年-2019年 ・世界及び中国の肝線維症治療薬市場現状 ・企業別分析：Bird Rock Bio, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Dicerna Pharmaceuticals, Inc., Digna Biotech, S.L., Genfit SA, Gilead Sciences, Inc., GNI Group Ltd., HEC Pharm Co., Ltd., Dr. Fなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析：インターフェロン、マロチ脂質、ヌクレオシド、その他 ・世界及び中国の肝線維症治療薬市場予測 2019年-2024年 ・肝線維症治療薬の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国の肝線維症治療薬市場動向・課題・機会 ・新規プロジェクトへの提言・結論

Liver Fibrosis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Liver Fibrosis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Liver Fibrosis Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Liver Fibrosis Drug market covering all important parameters.

The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Liver Fibrosis Drug industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Liver Fibrosis Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Liver Fibrosis Drug Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Liver Fibrosis Drug as well as some small players. At least 12 companies are included:
* Bird Rock Bio
* Bristol-Myers Squibb Company
* Celgene Corporation
* Dicerna Pharmaceuticals
* Digna Biotech
* S.L.
For complete companies list, please ask for sample pages.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Liver Fibrosis Drug market in gloabal and china.
* Interferon
* Maloti Lipid
* Nucleoside
* Other

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Research Center
* Hospital
* Clinic

Reasons to Purchase this Report:

* Estimates 2019-2024 Liver Fibrosis Drug market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

---

Chapter One Introduction of Liver Fibrosis Drug Industry
1.1 Brief Introduction of Liver Fibrosis Drug
1.2 Development of Liver Fibrosis Drug Industry
1.3 Status of Liver Fibrosis Drug Industry

Chapter Two Manufacturing Technology of Liver Fibrosis Drug
2.1 Development of Liver Fibrosis Drug Manufacturing Technology
2.2 Analysis of Liver Fibrosis Drug Manufacturing Technology
2.3 Trends of Liver Fibrosis Drug Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers
3.1 Bird Rock Bio
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Bristol-Myers Squibb Company
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Celgene Corporation
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Dicerna Pharmaceuticals
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Digna Biotech
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 S.L.
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Genfit SA
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……

Chapter Four 2014-2019 Global and Chinese Market of Liver Fibrosis Drug
4.1 2014-2019 Global Capacity, Production and Production Value of Liver Fibrosis Drug Industry
4.2 2014-2019 Global Cost and Profit of Liver Fibrosis Drug Industry
4.3 Market Comparison of Global and Chinese Liver Fibrosis Drug Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Liver Fibrosis Drug
4.5 2014-2019 Chinese Import and Export of Liver Fibrosis Drug

Chapter Five Market Status of Liver Fibrosis Drug Industry
5.1 Market Competition of Liver Fibrosis Drug Industry by Company
5.2 Market Competition of Liver Fibrosis Drug Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Liver Fibrosis Drug Consumption by Application/Type

Chapter Six 2019-2024 Market Forecast of Global and Chinese Liver Fibrosis Drug Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Liver Fibrosis Drug
6.2 2019-2024 Liver Fibrosis Drug Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Liver Fibrosis Drug
6.4 2019-2024 Global and Chinese Supply and Consumption of Liver Fibrosis Drug
6.5 2019-2024 Chinese Import and Export of Liver Fibrosis Drug

Chapter Seven Analysis of Liver Fibrosis Drug Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

Chapter Eight Global and Chinese Economic Impact on Liver Fibrosis Drug Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Liver Fibrosis Drug Industry

Chapter Nine Market Dynamics of Liver Fibrosis Drug Industry
9.1 Liver Fibrosis Drug Industry News
9.2 Liver Fibrosis Drug Industry Development Challenges
9.3 Liver Fibrosis Drug Industry Development Opportunities

Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

Chapter Eleven Research Conclusions of Global and Chinese Liver Fibrosis Drug Industry

Tables and Figures
Figure Liver Fibrosis Drug Product Picture
Table Development of Liver Fibrosis Drug Manufacturing Technology
Figure Manufacturing Process of Liver Fibrosis Drug
Table Trends of Liver Fibrosis Drug Manufacturing Technology
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
Figure Liver Fibrosis Drug Product and Specifications
Table 2014-2019 Liver Fibrosis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2014-2019 Liver Fibrosis Drug Production Global Market Share
……
……
Table 2014-2019 Global Liver Fibrosis Drug Capacity List
Table 2014-2019 Global Liver Fibrosis Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Global Liver Fibrosis Drug Manufacturers Capacity Share
Table 2014-2019 Global Liver Fibrosis Drug Key Manufacturers Production List
Table 2014-2019 Global Liver Fibrosis Drug Key Manufacturers Production Share List
Figure 2014-2019 Global Liver Fibrosis Drug Manufacturers Production Share
Figure 2014-2019 Global Liver Fibrosis Drug Capacity Production and Growth Rate
Table 2014-2019 Global Liver Fibrosis Drug Key Manufacturers Production Value List
Figure 2014-2019 Global Liver Fibrosis Drug Production Value and Growth Rate
Table 2014-2019 Global Liver Fibrosis Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Global Liver Fibrosis Drug Manufacturers Production Value Share
Table 2014-2019 Global Liver Fibrosis Drug Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Liver Fibrosis Drug Production
Table 2014-2019 Global Supply and Consumption of Liver Fibrosis Drug
Table 2014-2019 Import and Export of Liver Fibrosis Drug
Figure 2018 Global Liver Fibrosis Drug Key Manufacturers Capacity Market Share
Figure 2018 Global Liver Fibrosis Drug Key Manufacturers Production Market Share
Figure 2018 Global Liver Fibrosis Drug Key Manufacturers Production Value Market Share
Table 2014-2019 Global Liver Fibrosis Drug Key Countries Capacity List
Figure 2014-2019 Global Liver Fibrosis Drug Key Countries Capacity
Table 2014-2019 Global Liver Fibrosis Drug Key Countries Capacity Share List
Figure 2014-2019 Global Liver Fibrosis Drug Key Countries Capacity Share
Table 2014-2019 Global Liver Fibrosis Drug Key Countries Production List
Figure 2014-2019 Global Liver Fibrosis Drug Key Countries Production
Table 2014-2019 Global Liver Fibrosis Drug Key Countries Production Share List
Figure 2014-2019 Global Liver Fibrosis Drug Key Countries Production Share
Table 2014-2019 Global Liver Fibrosis Drug Key Countries Consumption Volume List
Figure 2014-2019 Global Liver Fibrosis Drug Key Countries Consumption Volume
Table 2014-2019 Global Liver Fibrosis Drug Key Countries Consumption Volume Share List
Figure 2014-2019 Global Liver Fibrosis Drug Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Liver Fibrosis Drug Consumption Volume Market by Application
Table 89 2014-2019 Global Liver Fibrosis Drug Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Liver Fibrosis Drug Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Liver Fibrosis Drug Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Liver Fibrosis Drug Consumption Volume Market by Application
Figure 2019-2024 Global Liver Fibrosis Drug Capacity Production and Growth Rate
Figure 2019-2024 Global Liver Fibrosis Drug Production Value and Growth Rate
Table 2019-2024 Global Liver Fibrosis Drug Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Liver Fibrosis Drug Production
Table 2019-2024 Global Supply and Consumption of Liver Fibrosis Drug
Table 2019-2024 Import and Export of Liver Fibrosis Drug
Figure Industry Chain Structure of Liver Fibrosis Drug Industry
Figure Production Cost Analysis of Liver Fibrosis Drug
Figure Downstream Analysis of Liver Fibrosis Drug
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Liver Fibrosis Drug Industry
Table Liver Fibrosis Drug Industry Development Challenges
Table Liver Fibrosis Drug Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Liver Fibrosis Drugs Project Feasibility Study

---